Difference between revisions of "Rudnicki 2014 United States Patent Application Publication"
From Bioblast
Beno Marija (talk | contribs) |
|||
| Line 10: | Line 10: | ||
{{Labeling | {{Labeling | ||
|area=Respiration, Patients | |area=Respiration, Patients | ||
|diseases=Obesity | |||
|organism=Mouse | |organism=Mouse | ||
|tissues=Skeletal muscle, Fat | |tissues=Skeletal muscle, Fat | ||
|preparations=Intact cells, Permeabilized cells | |preparations=Intact cells, Permeabilized cells | ||
|couplingstates=LEAK, ROUTINE, OXPHOS, ET | |||
|couplingstates=LEAK, ROUTINE, OXPHOS, | |||
|pathways=F, N, S, NS, ROX | |pathways=F, N, S, NS, ROX | ||
|instruments=Oxygraph-2k | |instruments=Oxygraph-2k | ||
}} | }} | ||
Latest revision as of 15:52, 13 November 2017
| Rudnicki MA, Yin Hang (2014) MICRORNA INHIBITORS. United States Patent Application Publication 1-49. |
Rudnicki MA, Yin Hang (2014) United States Patent Application Publication
Abstract: The present invention relates to microRNAs (miRNAs) that are associated with obesity. The present invention is directed to methods, compounds, and compositions for preventing and treating obesity, as well as related diseases, using a microRNA inhibitor. • Keywords: Patent
Labels: MiParea: Respiration, Patients
Pathology: Obesity
Organism: Mouse Tissue;cell: Skeletal muscle, Fat Preparation: Intact cells, Permeabilized cells
Coupling state: LEAK, ROUTINE, OXPHOS, ET
Pathway: F, N, S, NS, ROX
HRR: Oxygraph-2k
